These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15290344)

  • 1. Transglutaminase 2 in celiac disease: minireview article.
    Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
    Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten.
    Engström N; Sandberg AS; Scheers N
    Nutrients; 2015 Mar; 7(4):2134-44. PubMed ID: 25816160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
    Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
    J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
    Qiao SW; Piper J; Haraldsen G; Oynebråten I; Fleckenstein B; Molberg O; Khosla C; Sollid LM
    J Immunol; 2005 Feb; 174(3):1657-63. PubMed ID: 15661929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.
    Esposito C; Paparo F; Caputo I; Porta R; Salvati VM; Mazzarella G; Auricchio S; Troncone R
    Am J Gastroenterol; 2003 Aug; 98(8):1813-20. PubMed ID: 12907337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase and celiac disease.
    Esposito C; Caputo I; Auricchio S; Troncone R
    Prog Exp Tumor Res; 2005; 38():158-73. PubMed ID: 15746535
    [No Abstract]   [Full Text] [Related]  

  • 12. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
    Paolella G; Nanayakkara M; Sposito S; Lepretti M; Auricchio S; Esposito C; Barone MV; Martucciello S; Caputo I
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
    Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
    J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
    Skovbjerg H; Koch C; Anthonsen D; Sjöström H
    Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease.
    Büchold C; Hils M; Gerlach U; Weber J; Pelzer C; Heil A; Aeschlimann D; Pasternack R
    Cells; 2022 May; 11(10):. PubMed ID: 35626704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
    Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
    Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase--the key player in celiac disease: a review.
    Reif S; Lerner A
    Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.